The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.118.2.156

It is our opinion that the sudden withdrawal of tranquilizers from chronic psychotics living in a protective and reasonably permissive ward atmosphere will do no apparent harm to their condition in the majority of patients for a period ranging up to 5 months. Withdrawal symptoms were few, mild, and easily controlled, and asocial conduct usually subsided readily when the drugs were readministered. Drug intake as measured by duration, or dosage, or type of drug does not seem to be a factor as to how long a case can remain off medication socially. Neither do diagnosis, or apparent duration of illness, or age, except that those within the geriatric period seemed to remain off medication for the 90-day period in somewhat larger percentage. The results of this experiment seem to confirm a 1954 study(2) by a group at this hospital which found that clinical response and the pattern of resistive isolation in the Lorr Scale were the main improvements to be expected following the use of chlorpromazine and reserpine–and the present authors feel that this may well be true of all tranquilizers on this type of patient.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.